Cymat Financial Statements From 2010 to 2025
| CYMHF Stock | USD 0.08 0.02 18.00% |
Check Cymat Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cymat Technologies' main balance sheet or income statement drivers, such as , as well as many indicators such as . Cymat financial statements analysis is a perfect complement when working with Cymat Technologies Valuation or Volatility modules.
Cymat |
Cymat Technologies OTC Stock Operating Margin Analysis
Cymat Technologies' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Cymat Technologies Operating Margin | (1.35) % |
Most of Cymat Technologies' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cymat Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Cymat Technologies has an Operating Margin of -1.3468%. This is 124.99% lower than that of the Metals & Mining sector and 119.75% lower than that of the Materials industry. The operating margin for all United States stocks is 75.56% lower than that of the firm.
Cymat Technologies Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cymat Technologies's current stock value. Our valuation model uses many indicators to compare Cymat Technologies value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cymat Technologies competition to find correlations between indicators driving Cymat Technologies's intrinsic value. More Info.Cymat Technologies is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cymat Technologies' earnings, one of the primary drivers of an investment's value.About Cymat Technologies Financial Statements
Cymat Technologies stakeholders use historical fundamental indicators, such as Cymat Technologies' revenue or net income, to determine how well the company is positioned to perform in the future. Although Cymat Technologies investors may analyze each financial statement separately, they are all interrelated. For example, changes in Cymat Technologies' assets and liabilities are reflected in the revenues and expenses on Cymat Technologies' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Cymat Technologies. Please read more on our technical analysis and fundamental analysis pages.
Cymat Technologies Ltd., a materials technology company, manufactures and sells stabilized aluminum foam products worldwide. The company was incorporated in 2006 and is based in Mississauga, Canada. Cymat Technologies is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Cymat OTC Stock
Cymat Technologies financial ratios help investors to determine whether Cymat OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cymat with respect to the benefits of owning Cymat Technologies security.